|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：P689490 |
| 產(chǎn)品名稱(chēng)：Ponesimod |
| 產(chǎn)品CAS：854107-55-4 |
| 規(guī)格含量：1mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
P689490 |
| 名稱(chēng): |
Ponesimod |
| 別名: |
5-[3-Chloro-4-[((2R)-2,3-dihydroxypropyl)oxy]benz-(Z)-ylidene]-2-((Z)-propylimino)-3-(o-tolyl)thiazolidin-4-one; ACT 128800; (2Z,5Z)-5-[[3-Chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]methylene]-3-(2-methylphenyl)-2-(propylimino)-4-thiazolidinone |
| CAS號(hào): |
854107-55-4 |
| 分子式: |
C??H??ClN?O?S |
| 分子量: |
460.97 |
| 類(lèi)別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Ponesimod is an orally active sphingosine-1-phosphate receptor agonist. It protects against lymphocyte-mediated tissue inflammation. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
